Onsdag 30 April | 16:22:55 Europe / Stockholm

Prenumeration

2025-04-29 08:59:00

Redeye changes its Base Case and forecasts following a mixed Q1 report from Addnode. While macroeconomic risks exist, the current valuation implies a weaker development than our assumptions.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/